Navigation Links
Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call Date to November 5, 2012
Date:10/31/2012

EAST RUTHERFORD, N.J., Oct. 31, 2012 /PRNewswire/ --  Due to complications from the storm affecting the East Coast, Cambrex Corporation (NYSE: CBM, "Cambrex") will now report its results of the third quarter ended September 30, 2012 after the market closes Monday, November 5, 2012

The Company will also host a conference call to discuss the financial results Monday, November 5, 2012 at 4:45 p.m. EST.

 Third Quarter 2012 Earnings Conference Call When:  

Monday, November 5, 2012 at 4:45 p.m. Eastern Time Dial-in:  

1-888-430-8705 for U.S.1-719-325-2455 for International Passcode:  1704787Dial-in Replay:

1-888-203-1112 for U.S.1-719-457-0820 for InternationalPasscode:  1704787Available through Monday, November 12, 2012Webcast:www.cambrex.comAbout CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cambrex Reports Second Quarter 2012 Results
2. Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
3. Life Technologies Reschedules Issuance Of Third Quarter 2012 Performance Report And Associated Conference Call And Webcast to Thursday, November 1, 2012 Due To Expected Severe Weather Conditions
4. InterMune To Release Third Quarter Financial Results On November 7
5. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
6. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
7. Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update
8. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
9. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
10. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
11. Origin Agritech Limited to Announce FY2012 Third Quarter Financial Results on August 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... findings on what they believe could be a new and helpful biomarker for ... research. Click here to read it now. , Biomarkers are components ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
Breaking Biology News(10 mins):